Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

When can I expect my results?

Monday, January 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition has submitted a manuscript for the Nu.Q® Vet Cancer Test in cats, which is anticipated to be published in a peer-reviewed journal. This publication is expected to trigger a $5 million milestone payment. Additionally, the company has developed the first automated version of this test in collaboration with Fujifilm Vet Systems.
Price reaction · baseline $20.134 (2024-01-22T15:28:00.000Z) · hit during market hours · 11 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Submission of manuscript for Nu.Q® Vet Cancer Test in Cats.
  • Unlocking a $5 million contractual milestone payment.
  • First automated Nu.Q® Vet Cancer Test developed with Fujifilm.

Full Press Release Details

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for detecting cancer in cats.

What milestone payment is expected?

A $5 million contractual milestone payment is expected upon manuscript publication.

Who collaborated with Volition on the test?

Volition collaborated with Fujifilm Vet Systems to develop the automated test.

When will the results be available?

Results are expected following the publication of the manuscript in a peer-reviewed journal.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Volition cancer test Fujifilm milestone payment
Last updated: Jan 22, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk